This inventor holds 18 USPTO granted patents and 7 published patent applications and 4 EPO patents, primarily in Peptide Chemistry. Top assignees: California Institute of Technology, University of Rochester. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brea, CA (US) (2011 - 2022)
- Rochester, NY (US) (2012 - 2023)
Company Filing History:
9 out of 4,629 
9 out of 994 
Years Active: 2011-2025
Areas of Expertise:
Title: Rudi Fasan: Pioneering Innovator in Anticancer Agents and Alkane Oxidation
Introduction:
Rudi Fasan, hailing from Rochester, NY, is a renowned inventor and researcher primarily known for his contributions in the field of pharmaceuticals and biotechnology. With an impressive portfolio of 16 patents, Fasan has made significant breakthroughs in the development of anticancer and anti-inflammatory agents, as well as advancements in alkane oxidation. In this article, we explore his latest patents, career highlights, notable collaborations, and his ultimate contributions to the field of innovations and patents.
Latest Patents:
Fasan's most recent patents showcase his expertise in developing micheliolide derivatives and their potential application as both anticancer and anti-inflammatory agents. These derivatives stem from the sesquiterpene lactone micheliolide, and his work includes methods and compositions for their preparation. Fasan's innovative approaches have also extended to modifying parthenolide derivatives, further enhancing their effectiveness for treating cancer and inflammatory diseases.
Career Highlights:
Fasan's passion for scientific exploration led him to work with prestigious institutions throughout his career. Notably, he served as a key researcher and inventor at the California Institute of Technology, where he contributed to groundbreaking developments in the field of biotechnology. Continuing his journey, Fasan then joined the University of Rochester, where he pursued his research in medicinal chemistry and made significant strides in drug discovery.
Collaborations:
Fasan's exceptional work did not exist in isolation, as he collaborated with notable individuals who contributed to his research and achievements. Two prominent collaborators include Frances H Arnold and Peter Meinhold. Arnold, a fellow inventor and Nobel laureate, has made substantial advancements in enzymatic engineering, while Meinhold has excelled in the field of biocatalysis. Together, their collective expertise has undoubtedly enriched Fasan's accomplishments.
Conclusion:
Rudi Fasan's ingenious contributions to the world of innovation and patents have undoubtedly made a lasting impact. His pioneering work in developing micheliolide and parthenolide derivatives, coupled with his advancements in alkane oxidation, have the potential to revolutionize the fields of pharmaceuticals and biotechnology. Fasan's extensive collaboration with esteemed colleagues has further enriched his research and solidified his position as a leading figure in the industry. As we eagerly anticipate Fasan's future endeavors, we can confidently assert that his work represents a significant leap forward in the pursuit of improved cancer treatments and innovative industrial processes.
For more information on inventors, patents, and cutting-edge innovations, visit our website: idiyas.com.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile